KRTL Holding Group teams up for cannabis extraction breakthrough.

Sep.08.2022
KRTL Holding Group teams up for cannabis extraction breakthrough.
KRTL Holding Group is a leader in the development of cross-industry products, specializing in cannabis and alternative health.

KRTL Holding Group, Inc. (KRTL) is an innovator and pioneer in developing leading cross-products within the cannabis and alternative health industries with proprietary technology and methods. Its wholly-owned subsidiary, KRTL Biotech, has entered into a strategic alliance to exclusively deploy the most advanced mobile extraction equipment in collaboration with Entexs Corporation, a leading cannabis extraction manufacturer in the United States, focused on advanced closed-loop solutions and first-class THC remediation technology. KRTL has also joined forces with Iron Sight Industries, an established agricultural technology and logistics company, to bring their industry-leading expertise in rapid deployment of mobile systems based on US military special operations to the table. KRTL has played a significant role in the oil fracking industry in South Dakota, as well as in specialized cannabis and cannabis science lab testing and commercial extraction across state lines.


KRTL and Entexs have jointly developed a closed-loop extraction system that can process up to 2,000 pounds of biomass per day, solving a key issue that has made mobile extraction platforms commercially unviable. This system is designed specifically for remote and off-grid environments, with a self-sustaining power source, on-site cleaning system, and remote operation through mobile applications and digital interfaces.


KRTL has collaborated with Entexs and Iron Sight to deploy a disruptive technology specifically developed for KRTL, expanding its business reach in the US. KRTL is able to create unique approaches across interdisciplinary teams as a proprietary end product, and connect it with its extensive network of distributors, resulting in incredible revenue potential. This strategic fusion sets KRTL apart in the market, combining the compliance, banking, and legal expertise of KRTL's nationally operated public company with Iron Sight's military-trained rapid deployment team's operational efficiency and physical security, as well as Entexs' rugged and high-throughput mobile system.


KRTL is expected to finalize early deployment contracts in New Jersey, Oregon, Washington, and California, with more to follow. The advantage of the KRTL model is their ability to quickly move to areas with the highest demand. Since THC products based on marijuana cannot legally cross state lines, KRTL can enter these areas directly to produce distilled THC and isolates as final products, which they can then wholesale within the state or further refine into high-concentration/efficacy vape cartridges. This also allows them to quickly respond to and capitalize on new regulatory markets as they go live, positioning themselves as one of the first inter-state extraction solutions as recreational marijuana becomes more legalized and brings demand for marijuana-based extractions into the market.


According to KRTL, each extraction unit is expected to produce over 8,500 liters of medium-spectrum or broad-spectrum THC extract per year at full capacity. This is equivalent to approximately 8,500,000 grams of high-concentration retail vape formula, generating over $200 million in annual sales.


We are very excited about this opportunity. Typically, it takes 12-18 months to establish a physical extraction laboratory once all funding and suppliers are in place, and it is limited to a specific geographic area. If there is an exhaustion of demand or supply lines in that area, as we have seen in markets in Oregon and California, the cost of maintaining increased stakeholder risk could be significant. By creating a solution and method to quickly insert legal marijuana and marijuana production from remote legalized states, we significantly reduce stakeholder risk and maximize revenue potential.


Mr. Ball added, "For many years, I've worked with numerous extraction manufacturers, including some of the top names in the distillation and terpene extraction industries. I'm highly impressed by the precision engineering and cutting-edge functionality that Entexs has integrated into their product line. Typically, it's a disjointed, multi-step process beginning with extracting biomass into crude, then transferring that crude into separate isolation processes such as winterization or distillation, or multiple containers and physical separation stations. All of this is combined into one seamless, push-button closed-loop system from start to finish, resulting in biomass on one end and high-quality fractionated oil on the other.


Emil Bayan, the COO of Entexs, stated that they have been researching mobile prototypes, but when Daniel approached them seeking a partnership, they saw an opportunity to provide their first production unit exclusively for KRTL's operations. Bayan also added that their closed-loop technology for traditional fixed equipment has already revolutionized the cannabis and extraction industries, and they are excited to bring the same disruptive spirit to the design of KRTL's inaugural solution.


Statement:


This article is compiled from third-party information and is intended for industry professionals for the purpose of sharing and learning.


This article does not represent the perspective of 2FIRSTS, and 2FIRSTS cannot confirm the truthfulness and accuracy of the content. The compilation of this article is solely for industry exchange and research purposes.


Due to limitations in our ability to accurately translate, this article may not fully convey the message of the original text. Please refer to the original article for accuracy.


2FIRSTS maintains full alignment with the Chinese government on any domestic issues, as well as matters concerning Hong Kong, Macau, Taiwan, and foreign relations.


The compilation of information is the property of the original media and the author. If there is any infringement, please contact us to remove it.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Research | Swedish Study Finds Oral Lesions in 79% of Examined Nicotine Pouch Users, With Distinct Tissue Responses
Research | Swedish Study Finds Oral Lesions in 79% of Examined Nicotine Pouch Users, With Distinct Tissue Responses
A new Swedish study found oral mucosal lesions in 79% of examined nicotine pouch users and 89% of tobacco-derived snus users, with different tissue-response patterns between the two categories. For manufacturers and regulators, the findings shift attention toward product formulation, flavouring, pouch materials and local oral exposure, not only whether a product contains tobacco. The study found no higher prevalence of caries or periodontal disease, but it could not establish causality, long-term outcomes or differences between individual products or designs.
Special Report
Jul.27
Ireland’s Vape Tax Raises €22 Million in Nine Months as Government Considers 2027 Budget Changes
Ireland’s Vape Tax Raises €22 Million in Nine Months as Government Considers 2027 Budget Changes
According to Irish media outlets Highland Radio and BreakingNews.ie, the Irish government is considering whether to adjust vape tax policy in the 2027 Budget. The tax has generated about €22 million ($24 million) in revenue during its first nine months. While no increase has been confirmed, the revenue performance could influence future fiscal discussions. Any tax rise could increase product costs and potentially affect retail prices.
Aug.12
FDA Authorizes Four More Nicotine Pouches as Review Pilot Expands Beyond Initial Decisions
FDA Authorizes Four More Nicotine Pouches as Review Pilot Expands Beyond Initial Decisions
The FDA has authorized four additional on! nicotine pouches, bringing the U.S. total to 30. The decision marks another outcome of the agency’s nicotine pouch review pilot, whose communication and review practices are now being applied more broadly across the category. It also extends Helix’s authorized portfolio from on! PLUS to the earlier on! line. Yet all FDA-authorized nicotine pouches still come from subsidiaries of PMI or Altria, underscoring how concentrated U.S. regulatory access remains.
Aug.05
Product | SKE Launches FRESA PRO in the U.S., Introducing Fresh Lock Technology for E-Liquid Management in High-Capacity Vapes
Product | SKE Launches FRESA PRO in the U.S., Introducing Fresh Lock Technology for E-Liquid Management in High-Capacity Vapes
Shenzhen SKE Technology has launched the FRESA PRO in the United States, a high-capacity rechargeable disposable vape featuring Fresh Lock electromagnetic valve supply control technology. The device combines a claimed capacity of up to 40,000 puffs, dual mesh coils, dual output modes and a transparent tank design. The launch reflects the high-capacity disposable vape segment’s shift from puff-count competition toward improved e-liquid management and device-level experience.
Aug.03
2Firsts Data | China’s Vape Exports Rise 3.1% in H1 2026 as 6-Methyl Nicotine-Related Products Surge 65.2%
2Firsts Data | China’s Vape Exports Rise 3.1% in H1 2026 as 6-Methyl Nicotine-Related Products Surge 65.2%
China’s vape exports showed resilience in the first half of 2026 after a short-term shock from China’s export rebate adjustment. But customs data points to more than a simple recovery: the structure of growth is changing. Vaping devices and atomization hardware emerged as the strongest growth driver, while nicotine-containing vaping products remained broadly stable. Meanwhile, nicotine substitute-related products represented by 6-methyl nicotine expanded rapidly, becoming a new category to watch for both industry and regulators. After the U.S. market went through a cycle of shortages, replenishment and inventory rebuilding in 2025, China’s vape supply chain is entering a new phase of reallocation.
Special Report
Jul.20
BAT's VELO Partners With McLaren F1 Team for Global Fan Campaign to Expand Nicotine Pouch Brand Reach
BAT's VELO Partners With McLaren F1 Team for Global Fan Campaign to Expand Nicotine Pouch Brand Reach
BAT-owned nicotine pouch brand VELO and the McLaren Mastercard Formula 1 Team have launched a global fan engagement campaign offering motorsport enthusiasts opportunities to win exclusive team-related experiences. The initiative aims to connect racing culture, fan interaction and VELO’s brand experience across global markets. The partnership reflects BAT’s broader strategy of expanding modern nicotine product brands beyond traditional tobacco categories through lifestyle and cultural marketing.
Jul.23